Effects of different dietary fatty acids on the fatty acid compositions and the expression of lipid metabolic-related genes in mammary tumor tissues of rats

Nutrition and Cancer

Volumn 60, Issue 6, 2008, Pages 810-825

  Wei, Na ^a   Wang, Bin ^a   Zhang, Qian Yong ^a   Mi, Man Tian ^a   Zhu, Jun Dong ^a   Yu, Xiao Ping ^a   Yuan, Jia Ling ^a   Chen, Ka ^a   Wang, Jian ^a   Chang, Hui ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5,8,11,14,17 ICOSAPENTAENOIC ACID; ARACHIDONATE 5 LIPOXYGENASE; CERVONIC ACID; CYCLOOXYGENASE 2; FATTY ACID; FATTY ACID SYNTHASE; MESSENGER RNA; METHYLNITROSOUREA; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; SATURATED FATTY ACID;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER INCIDENCE; CANCER PREVENTION; CANCER TISSUE; CONTROLLED STUDY; DIET THERAPY; FAT INTAKE; FEMALE; FOOD COMPOSITION; GENE EXPRESSION REGULATION; LIPID COMPOSITION; LIPID METABOLISM; NONHUMAN; RAT; WEIGHT REDUCTION;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACID; CYCLOOXYGENASE 2; DIETARY FATS; FATTY ACID SYNTHETASE COMPLEX; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; RATS; RATS, SPRAGUE-DAWLEY; WEIGHT GAIN;

RATTUS;

EID: 56249124249     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580802192858     Document Type: Article

References (46)

1. Escrich E, Solanas M, Soler M, Ruiz de Villa MC, Sanchez JA, et al.: Dietary polyunsaturated n-6 lipids effects on the growth and fatty acid composition of rat mammary tumors. J Nutr Biochem 12, 536-549, 2001.
2. Gago-Dominguez M, Yuan JM, Sun CL, Lee HP, and Yu MC: Opposing effects of dietary n-3 and n-6 fatty acids on mammary carcinogenesis: the Singapore Chinese Health Study. Br J Cancer 89, 1686-1692, 2003.
3. Hardman WE: Dietary canola oil suppressed growth of implanted MDA-MB 231 human breast tumors in nude mice. Nutr Cancer 57, 177-183, 2007.
4. Simopoulos AP: The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 56, 365-379, 2002.
5. Terry PD, Rohan TE, and Wolk A: Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: a review of the epidemiologic evidence. Am J Clin Nutr 77, 532-543, 2003.
6. Heller AR, Stehr SN, and Koch T: Omega 3 Fatty Acids in Clinical Nutrition. Hauppage, NY: Nova Science Pub Inc., 2006.
7. Chen KX, He M, Dong SF, and Wang JF: Incidence, mortality and survival rates of female mammary tumor in Tianjin, China. Chin J Oncol 24, 573-575, 2002.
8. Wakil S: Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry 28, 4523-4530, 1989.
9. Kuhajda FP: Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 16, 202-208, 2000.
10. Wang YY, Kuhajda FP, Li J, Finch TT, Cheng P, et al.: Fatty acid synthase as a tumor marker: its extracellular expression in human mammary tumor. J Exp Ther Oncol 4, 101-110, 2004.
11. Yang YA, Han WF, Morin PJ, Chrest FJ, and Pizer ES: Activation of fatty acids synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Exp Cell Res 279, 80-90, 2002.
12. Sheng H, Shao J, Washington MK, and DuBois RN: Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J Biol Chem 276, 18075-18081, 2001.
13. Hoque A, Lippman SM, Wu TT, Xu Y, Liang ZD, et al.: Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention. Carcinogenesis 26, 785-791, 2005.
14. Larkins TL, Nowell M, Singh S, and Sanford GL: Inhibition of cyclooxygenase-2 decreases mammary tumor cell motility, invasion and matrix metalloproteinase expression. BMC Cancer 6, 181, 2006.
15. Zhai FY, He YN, Ma GS, Li YP, Wang ZH, et al.: Study on the current status and trend of food consumption among Chinese population. Zhonghua Liu Xing Bing Xue Za Zhi (Chinese), 26, 485-488, 2005.
16. Hardman WE, Munoz J, and Cameron IL: Role of lipid peroxidation and antioxidant enzymes in omega 3 fatty acids induced suppression of mammary tumor xenograft growth in mice. Cancer Cell Int 2, 10-18, 2002.
17. Lu S, Zhang X, Badawi AF, EI-Sohemy A, and Archer MC: Cyclooxygenase-2 inhibitor celecoxib inhibits promotion of mammary tumorigenesis in rats fed a high fat diet rich in n-6 polyunsaturated fatty acids. Cancer Lett 184, 7-12, 2002.
18. Young S and Hallowes RC: Tumors of the mammary gland. IARC Sci Publ 5, 31-73, 1973.
19. Folch J, Lees M, and Sloane Stanley GH: A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem 226, 497-509, 1957.
20. Rogers AE: Diet andmammary tumor: studies in laboratory animals. J Nutr 127, 933S-935S, 1997.
21. Richardson S, Gerber M, and Cenee S: The role of fat, animal protein and some vitamin consumption in mammary tumor: a case-control study in Southern France. Int J Cancer 48, 1-9, 1991.
22. Do MH, Lee SS, Jung PJ, and Lee MH: Intake of dietary fat and vitamin in relation to mammary tumor risk in Korean women: a case-control study. J Korean Med Sci 18, 534-540, 2003.
23. Binukumar B and Mathew A: Dietary fat and risk of mammary tumor. World J Surg Oncol 18, 45-51, 2005.
24. Zusman I, Gurevich P, Madar Z, Nyska A, Korol D, et al.: Tumor-promoting and tumor-protective effects of high-fat diets on chemically induced mammary cancer in rats. Anticancer Res 17, 349-356, 1997.
25. Gerber M: Olive oil, monounsaturated fatty acids and cancer. Cancer Lett 114, 91-92, 1997.
26. Owen RW, Giacosa A, Hull WE, Haubner R, Würtele G, et al.: Olive-oil consumption and health: the possible role of antioxidants. Lancet Oncol 1, 107-112, 2000.
27. Hardy S, St-Onge GG, Joly E, Langelier Y, and Prentki M: Oleate promotes the proliferation ofmammary tumor cells via the G protein-coupled receptor GPR40. J Biol Chem 280, 13285-13291, 2005.
28. Pala V, Krogh V, Muti P, Chajès V, Riboli E, et al.: Erythrocyte membrane fatty acids and subsequent mammary tumor: a prospective Italian study. J Natl Cancer Inst 93, 1088-1095, 2001.
29. Calder PC and Grimble RF: Polyunstaturated fatty acids, inflammation and immunity. Eur J Clin Nutr 56, S14-19, 2002.
30. Rose DP: Effects of dietary fatty acids on breast and prostate cancers: evidence from in vitro experiments and animal studies. Am J Clin Nutr 66, 1513S-1522S, 1997.
31. Cohen LA, Thompson DO, Choi K, Karmali RA, and Rose DP: Dietary fat and mammary cancer. II. Modulation of serum and tumor lipid composition and tumor prostaglandins by different dietary fats: association with tumor incidence patterns. J Natl Cancer Inst 77, 43-51, 1986.
32. Sauer LA, Dauchy RT, Blask DE, Krause JA, Davidson LK, et al.: Eicosapentaenoic acid suppresses cell proliferation in MCF-7 human mammary tumor xenografts in nude rats via a pertussis toxin-sensitive signal transduction pathway. J Nutr 135, 2124-2129, 2005.
33. Nieves D and Moreno JJ: Effect of arachidonic and eicosapentaenoic acid metabolism on RAW 264.7 macrophage proliferation. J Cell Physiol 208, 428-434, 2006.
34. Alo' PL, Visca P, Marci A, Mangoni A, Botti C, et al.: Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients. Cancer 77, 474-482, 1996.
35. Jensen V, Ladekarl M, Holm-Nielsen P, Melsen F, and Soerensen FB: The prognostic value of oncogenic antigen 519 (OA-519) expression and proliferative activity detected by antibody MIB-1 in node-negative mammary tumor. J Pathol 176, 343-352, 1995.
36. Swinnen JV, Van Veldhoven PP, Timmermans L, De Schrijver E, Brusselmans K, et al.: Fatty acid synthase drives the synthesis of phospholipids partitioning into detergent-resistant membrane microdomains. Biochem Biophys Res Commun 302, 898-903, 2003.
37. Menendez JA, Vellon L, and Lupu R: Targeting fatty acid synthase-driven lipid rafts: a novel strategy to overcome trastuzumab resistance in mammary tumor cells. Med Hypotheses 64, 997-1001, 2005.
38. Kim HK, Choi S, and Choi H: Suppression of hepatic fatty acid synthase by feeding alpha-linolenic acid rich perilla oil lowers plasma triacylglycerol level in rats. J Nutr Biochem 15, 485-492, 2004.
39. Dobrzyn A, Dobrzyn P, Miyazaki M, and Ntambi JM: Polyunsaturated fatty acids do not activate AMP-activated protein kinase in mouse tissues. Biochem Biophys Res Commun 332, 892-896, 2005.
40. Smith WL, DeWitt DL, and Garavito RM: Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69, 145-182, 2000.
41. Chang SH, Liu CH, Conway R, Han DK, Nithipatikom K, et al.: Role of prostaglandin E2-dependent angiogenic swith in cyclooxygenase 2-induced mammary tumor progression. Proc Natl Acad Sci USA 101, 591-596, 2004.
42. Shimizu T and Wolfe LS: Arachidonic acid cascade and signal transduction. J Neurochem 55, 1-15, 1990.
43. Moretti RM, Montagnani Marelli M, Sala A, Motta M, and Limonta P: Activation of the orphan nuclear receptor RORalpha counteracts the proliferative effect of fatty acids on prostate cancer cells: crucial role of 5-lipoxygenase. Int J Cancer 112, 87-93, 2004.
44. Horia E and Watkins BA: Complementary actions of docosahexaenoic acid and genistein on COX-2, PGE2 and invasiveness in MDA-MB-231 mammary tumor cells. Carcinogenesis 28, 809-815, 2007.
45. Hedelin M, Chang ET, Wiklund F, Bellocco R, Klint A, et al.: Association of frequent consumption of fatty fish with prostate cancer risk is modified by COX-2 polymorphism. Int J Cancer 120, 398-405, 2007.
46. Bommareddy A, Arasada BL, Mathees DP, and Dwivedi C: Chemopreventive effects of dietary flaxseed on colon tumor development. Nutr Cancer 54, 216-222, 2006.